PATIENCE DAVID (Chief Financial Officer) purchased 1.4% of their position (3.66K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market purchase worth $15.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/23/2026ACC: 0001628280-26-010606
Officer· Chief Financial Officer
Since Feb 2026
+3.66K
Net shares
Net buyer
$15.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3.66K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.66K
Price / share
$4.10
Trade value
$14.99K
% of position
1.4%
2/23/2026
265K→268.66K
Total
Net shares
+3.66K
Net value
$14.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | P · Purchase | +3.66K | $4.10 | $14.99K | 1.4% | 265K | 268.66K |
| Total | +3.66K | $14.99K | ||||||
Derivative Transactions0
No derivative transactions reported